TrialJournal of child and adolescent psychopharmacology2014

Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.

Ann C Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.